Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Rite Aid Corporation

Walgreens Boots Alliance (WBA), CVS Health (CVS), and Rite Aid (RAD): Buy, Hold or Sell?

With rising healthcare spending, the drugstore industry is poised to witness solid growth amid heightened demand. As a result, leading industry players CVS Health (CVS), Walgreens Boots Alliance (WBA), and Rite Aid (RAD) stand to benefit. However, should you Buy, Hold, or Sell these stocks? Keep reading to find out.

StockNews.com

1 Drug Store Stock to Buy in 2023 and 1 to Sell

The demand for drugstore products is significantly rising owing to the growing prevalence of chronic diseases, an aging population, and favorable government policies. Hence, investing in fundamentally sound drugstore stock CVS Health (CVS) could be wise. However, it might be wise to avoid Rite Aid (RAD) due to its deteriorating…

StockNews.com

2 Downgraded Stocks to Steer Clear of This Week

Following a better-than-expected September job report, the Fed is expected to maintain its hawkish stance in the coming months. Amid increasing recession fears, the bear market might remain. Therefore, we think it could be wise to steer clear of fundamentally weak stocks Bed Bath & Beyond (BBBY) and Rite Aid…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

1 Drugstore Stock to Buy Right Now and 2 to Sell

An ageing population and rising healthcare expenditure due to increased awareness among the masses are expected to boost demand for drugstore products. On the other hand, the stock market is experiencing heightened volatility amid the ongoing macroeconomic challenges. While we think investors should buy drugstore stock CVS Health (CVS), fundamentally…

StockNews.com

4 Consumer Staples Stocks to Avoid

Consumer staples companies are known for performing relatively well during a market turmoil because of inelastic demand for their products. However, Wall Street analysts expect fundamentally weak consumer staples stocks Japan Tobacco (JAPAY), National Beverage (FIZZ), Grocery Outlet (GO), and Rite Aid (RAD) to decline more than 10% in the…

StockNews.com

Rite Aid Shares Jumped 40% Last Week - Buy, Sell, Hold?

Rite Aid (RAD) shares soared last week after the company reported stronger-than-expected first-quarter revenue growth and issued an upbeat sales forecast. However, given the company’s increasing losses and projected interest rate hikes, is it worth buying the stock now? Let’s find out.

StockNews.com

Effect Of Roe Vs. Wade Ruling - Pharmacies Ration Contraceptive Pills

Major pharmacies like CVS Health Corp (NYSE:CVS), Walmart Inc (NYSE:WMT), and Rite Aid Corporation (NYSE:RAD) have put a limit on purchases or deliveries of Plan B and other emergency contraceptive pills, writes Wall Street Journal. The move comes as demand for contraceptive pills spiked following the Supreme Court ruling overturning a constitutional right to abortion. These were in…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Is Rite Aid Stock a Buy After Reporting Strong Q4 Results?

Leading pharmaceutical retailer Rite Aid (RAD) shares jumped last week thanks to its stronger-than-expected fourth-quarter revenue growth driven by an increase in same-store and pharmacy sales. Although the company’s strategic initiatives to boost membership should bode well for the stock, its struggling Elixir business and expanding losses could lead to…

StockNews.com

Analyzing Rite Aid Corporation's Short Interest

Rite Aid Corporation's (NYSE:RAD) short percent of float has risen 7.57% since its last report. The company recently reported that it has 17.61 million shares sold short, which is 32.54% of all regular shares that are available for trading.

Benzinga

Deutsche Bank Sees Potential 'Dramatic Negative Inflection Point' For Rite Aid

Ahead of the Company's fiscal Q4 results on April 14, Deutsche Bank downgraded Rite Aid Corporation (NYSE:RAD) to Sell from Hold with a price target of $1, down from $16. Analyst George Hill believes COVID has "hastened the decline" for the Company, and he sees the potential for a "dramatic negative inflection point"…

Benzinga

People

Kritika SarmahHer

727 stories

Mangeet Kaur BounsMangeet

595 stories

George Hill

48 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Walgreens Boots Alliance

CVS Health Corporation

61 stories

RAD

60 stories

Bed Bath & Beyond Inc

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.